Related references
Note: Only part of the references are listed.Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria
M. Tang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Crystal structure of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis
Shan Shan et al.
FASEB JOURNAL (2011)
Impact of high-throughput screening in biomedical research
Ricardo Macarron et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase
Gian Filippo Ruda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Fragment-Based Lead Discovery: Screening and Optimizing Fragments for Thermolysin Inhibition
Lisa Englert et al.
CHEMMEDCHEM (2010)
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments
Sudipto Mukherjee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Rapid Context-Dependent Ligand Desolvation in Molecular Docking
Michael M. Mysinger et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors
Rafaela S. Ferreira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept
Michael Lisurek et al.
MOLECULAR DIVERSITY (2010)
Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring
Ran Friedman et al.
CHEMMEDCHEM (2009)
Managing protein flexibility in docking and its applications
Chandrika B-Rao et al.
DRUG DISCOVERY TODAY (2009)
One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
Chidochangu P. Mpamhanga et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Molecular docking and ligand specificity in fragment-based inhibitor discovery
Yu Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
Docking for fragment inhibitors of AmpC β-lactamase
Denise G. Teotico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases
Ruth Brenk et al.
CHEMMEDCHEM (2008)
Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis
Christine M. Crane et al.
CHEMMEDCHEM (2008)
Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-D-erythritol kinase -: ligand recognition in a template for antimicrobial drug discovery
Tanja Sgraja et al.
FEBS JOURNAL (2008)
Recent developments in fragment-based drug discovery
Miles Congreve et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase
Kerim Babaoglu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering?: An investigation of the advantages and pitfalls of post-filtering
Daniel Muthas et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Inhibitors of the kinase IspE: structure-activity relationships and co-crystal structure analysis
Anna K. H. Hirsch et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
High-throughput screening for human galactokinase inhibitors
Klaas J. Wierenga et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Virtual screening strategies in drug discovery
Campbell McInnes
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
The non-mevalonate pathway of isoprenoid precursor biosynthesis
William N. Hunter
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The function of terpene natural products in the natural world
Jonathan Gershenzon et al.
NATURE CHEMICAL BIOLOGY (2007)
Nonphosphate inhibitors of IspE protein, a kinase in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antirnalarial therapy
Anna K. H. Hirsch et al.
CHEMMEDCHEM (2007)
Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors
Jeffrey Jie-Lou Liao
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Interpreting steep dose-response curves in early inhibitor discovery
Brian K. Shoichet
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors
Upasana Singh et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Fragment-based drug design: How big is too big?
Philip J. Hajduk
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Prediction of protein-ligand interactions. Docking and scoring: Successes and gaps
Andrew R. Leach et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa et al.
NATURE CHEMICAL BIOLOGY (2006)
Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3β inhibitors
T Polgár et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists
BS Edwards et al.
MOLECULAR PHARMACOLOGY (2005)
Here Be dragons: Docking and screening in an uncharted region of chemical space
R Brenk et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Isoprenoid biosynthetic pathways as anti-infective drug targets
F Rohdich et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Hierarchical docking of databases of multiple ligand conformations
DM Lorber et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy
JA Erickson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Comparing performance of computational tools for combinatorial library design
E Evensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Crystal structure of 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinase, an enzyme in the non-mevalonate pathway of isoprenoid synthesis
T Wada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biosynthesis of isoprenoids:: Crystal structure of 4-diphosphocytidyl-2C-methyl-D-erythritol kinase
L Miallau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Essential Bacillus subtilis genes
K Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Designing screens: How to make your hits a hit
WP Walters et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function
M Zalacain et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2003)
Virtual screening to enrich hit lists from high-throughput screening: A case study on small-molecule inhibitors of angiogenin
JL Jenkins et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2003)
Kinase inhibitors and the case for CH•••O hydrogen bonds in protein-ligand binding
AC Pierce et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2002)
Characterization of the depletion of 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase in Escherichia coli and Bacillus subtilis
TL Campbell et al.
JOURNAL OF BACTERIOLOGY (2002)
Mevalonate and nonmevalonate pathways for the biosynthesis of isoprene units
T Kuzuyama
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B
TN Doman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae
BJ Akerley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The non-mevalonate pathway of isoprenoids: genes, enzymes and intermediates
F Rohdich et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis
AM Paiva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways
Y Boucher et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
